Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Parkinson's Disease
Trial Information
Research study of investigational medication for people with new-onset Parkinson's Disease while taking a Dopamine Agonist (e.g. Requip)
QUEST Research Institute is looking for people with early idiopathic Parkinson's Disease to participate in a research study for an investigational treatment
Patient Inclusion Criteria:
- Receiving treatment of a single dopamine agonist for at least 4 weeks
- Between 30 and 80 years old
- Diagnosed with Parkinson's Disease for less than 5 years
Patient Exclusion Criteria: Please Call Site to discuss exclusionary criteria
Dolly Niles
QUEST Research Institute
31000 Telegraph, Suite 230
Bingham Farms, MI 48025
Phone: 248-644-7770
EMail: www.questri.com
View Google Map
Research Center Information: QUEST Research Institute
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
